NCT01693718已完成2 期
A Multicenter Phase II Study of Intensive Concomitant Chemoradiotherapy With Filgrastim (GCSF) for Patients With Locoregionally Advanced Head and Neck Cancer
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 44
- 试验地点
- 2
- 主要终点
- Response Rates
研究概览
简要总结
The goal of the study is to test a particular combination of drugs and determine their ability to completely eliminate head and neck cancer.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 59 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Response Rates
时间窗: 2-5 years
To evaluate the activity of 5 cycles of C-FHX/G-CSF in previously untreated patients with stage II and IV locoregionally advanced head and neck cancer.
次要结局
- Side effects of study regimen(2-5 years)
- Feasibility of administering adjuvant CRA and interferon alfa2a(2-5 years)
研究者
研究点 (2)
Loading locations...
相似试验
撤回
2 期
Study to Test the Benefit and Safety of GM-CT-01 in Combination With 5-FU to Treat Bile Duct and Gall Bladder CancerCancer of the Bile DuctGallbladder CancerNCT00386516Galectin Therapeutics Inc.
已完成
不适用
A Combination Drug Including Fimasartan and Statins in Patients With Hypertension and DyslipidemiaHypertension and DyslipidemiaNCT04554953Boryung Pharmaceutical Co., Ltd10,877
已完成
2 期
Nilotinib + Pegylated Interferon Alpha 2a for Untreated Chronic Phase Chronic Myelogenous LeukemiaChronic Myelogenous LeukemiaNCT01294618Hospices Civils de Lyon60
已完成
1 期
Safety and Efficacy of APX005M With Gemcitabine and Nab-Paclitaxel With or Without Nivolumab in Patients With Previously Untreated Metastatic Pancreatic AdenocarcinomaMetastatic Pancreatic AdenocarcinomaNCT03214250Parker Institute for Cancer Immunotherapy129
进行中（未招募）
1 期
Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast CancerBreast CancerNCT01872260Novartis Pharmaceuticals255